Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Oncology
»
Gynecologic Neoplasms
20. November 2025
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 15965
Articles 1 - 20 / 319283
Impact of High-Risk HPV Infection on PI3K, MALAT1, H19 and LINC00460 Expression in Cervical Cells.
J Cell Mol Med
Neisi N, Mousavikish F, Bastani MN, Parsanahad M, Pirmoradi R.
PMID: 41261348 [PubMed - indexed for MEDLINE]
Translating genomic insights into therapy: an NGS-based mutation profiling study in breast cancer.
Med Oncol
Bhavnagari HM, Raval AP, Tarapara BV, Joshi JS, Shah FD.
PMID: 41261306 [PubMed - indexed for MEDLINE]
Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations and risk of lifestyle-related cancers in the prostate, lung, colorectal, and ovarian cancer screening trial.
BJC Rep
Malcomson FC, Shams-White MM, Reedy J, Huang WY, Moore SC, Loftfield E.
PMID: 41261199 [PubMed]
Pre-operative Radiotherapy in Locally Advanced Breast Cancer: A Narrative Review.
Int J Radiat Oncol Biol Phys
Arif A, Khan AJ.
PMID: 41260528 [PubMed - as supplied by publisher]
Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02.
Ann Oncol
Hurvitz SA, Loi S, O'Shaughnessy J, Okines AFC, Tolaney SM, Sohn J, Saura C, Zhu X, Cameron D, Bachelot T, Hamilton E, Curigliano G, Wolff AC, Harbeck N, Masuda N, Vahdat L, Zaman K, Valdes-Albini F, Block M, Pluard T, Tan TJ, Gawryletz C, Chan A, Bedard PL, Yerushalmi R, Xu B, Schmitt M, Xie D, Borges VF, HER2CLIMB-02 study investigators.
PMID: 41260264 [PubMed - as supplied by publisher]
Kinetics and determinants of ESR1 mutation detection in metastatic breast cancer.
Ann Oncol
Cabel L, Berger F, Bachelot T, Pistilli B, Dalenc F, Rouge TM, Sabatier R, Lortholary A, Marques S, Vibert J, Renault S, Hardy-Bessard AC, Delaloge S, Pradines A, Callens C, Bidard FC.
PMID: 41260263 [PubMed - as supplied by publisher]
ASSOCIATION BETWEEN TYPE AND LOCATION OF GERMLINE BRCA1/2 PATHOGENIC OR LIKELY PATHOGENIC VARIANTS WITH PHENOTYPE AND PROGNOSIS IN YOUNG PATIENTS WITH BREAST CANCER: RESULTS FROM AN INTERNATIONAL COHORT STUDY.
Ann Oncol
Toss A, Blondeaux E, Tenedini E, Bonamici L, Graffeo R, Livraghi L, Villarreal-Garza C, Molho RB, Kwong A, Balmana J, Wildiers H, Agostinetto E, Phillips KA, Pogoda K, Renaud T, Rousset-Jablonski C, Ferrari A, Moore HCF, Peccatori FA, Paluch-Shimon S, Fruscio R, Micheri C, Wong SM, Cui W, Vernieri C, Lee M, De Marchis L, Couch FJ, Del Mastro L, Puglisi F, Meireles PA, Kemp Z, Matikas A, Plichta J, Del Pilar Estevez-Diz M, Di Meglio A, Cichowska-Cwalinska N, Gianni C, Yerushalmi R, Sanchez-Bayona R, Mrinakova B, Matos L, Bianchini G, Caleffi M, Krivokuca A, Abdou Y, Mariño-Mariño M, Parokonnaya A, Okano M, Antone N, Saavedra C, Sonnenblick A, Duchnowska R, Pais HL, Harbeck N, Cortesi L, Delucchi V, De Angelis C, Lambertini M.
PMID: 41260260 [PubMed - as supplied by publisher]
Feet Cooling As a Preventive Strategy against Chemotherapy-Induced Peripheral Neuropathy in Advanced Breast Cancer Patients: A Randomized Clinical Trial.
Clin Breast Cancer
Asadi F, Emadi E, Chaman R, Porouhan P, Nematshahi M, PeyroShabany B, Zare MS, Javadinia SA.
PMID: 41260178 [PubMed - as supplied by publisher]
Diagnostic Heterogeneity and Healthcare Access Disparities: Latent Systemic Bias in Global Estimates of Male Breast Cancer Burden.
Clin Breast Cancer
Zhang J.
PMID: 41260176 [PubMed - as supplied by publisher]
CNT as a robust delivery vehicle for anti-breast cancer drugs: A combined DFT and in-silico study.
J Mol Graph Model
Pal S, Ghosh NN, Pati SK, Mandal M.
PMID: 41260129 [PubMed - as supplied by publisher]
Neoadjuvant chemotherapy followed by interval surgery versus primary debulking surgery in FIGO stage III-IV epithelial ovarian cancer: A systematic review and meta-analysis.
Eur J Cancer
Secchi M, Signorelli M, Rulli E, Maruccio M, Di Martino G, Spadaro D, Giudice E, Turinetto M, Landoni F, Restaino S, Vizzielli G, Martinelli F, Lorusso D.
PMID: 41259943 [PubMed - as supplied by publisher]
Letter Re: Impact of early discontinuation of adjuvant endocrine therapy on survival in breast cancer: A target trial emulation.
Eur J Cancer
Woolpert KM, Collin LJ, Cronin-Fenton DP.
PMID: 41259942 [PubMed - as supplied by publisher]
Utility of CA125 KELIM in predicting benefit from hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer: pooled analysis of KGOG3042 and KOV-HIPEC-01.
Int J Gynecol Cancer
Cho HW, Chang SJ, Lim MC, Kim JH, Park SY, Lee JY, Suh DH, Song JY, Choi MC, Kim MK, Kim HS, Carrot A, You B.
PMID: 41259849 [PubMed - as supplied by publisher]
Survival impact and prognostic factors of secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a systematic review and trial-level meta-analysis.
Int J Gynecol Cancer
Kim JH, Lim MC, Kim ET, Kim U, Halder S, Park SY, Harter P, Bristow R, Zang R, Chi D, Fotopoulou C.
PMID: 41259845 [PubMed - as supplied by publisher]
Identifying high-risk relapse in early-stage I to II ovarian cancer using the CA125 ELIMination rate constant K (KELIM) score: a Gynecologic Cancer InterGroup individual patient-data meta-analysis.
Int J Gynecol Cancer
Corbaux P, You B, Kagimura T, Glasspool RM, McNeish I, Cook A, Mirza MR, Lindemann K, Tinker AV, Welch S, Ray-Coquard IL, Subtil F, Colomban O, Péron J, Karamouza E, Kelly C, Lewsley LA, Paoletti X, Yanaihara N.
PMID: 41259844 [PubMed - as supplied by publisher]
Pharmacogenomic Impact on Breast Cancer Survival for Black Zimbabwean Patients on Tamoxifen.
JCO Glob Oncol
Mazhindu TA, Chase ED, Joel M, Ndlovu N, Borok MZ, Masimirembwa C, Hendricks AE, Consortium for Genomics and Therapeutics in Africa (CGTA).
PMID: 41259728 [PubMed - indexed for MEDLINE]
[Selective, controlled release of ruthenium-based therapeutic agents: a targeted weapon against ovarian cancer].
Med Sci (Paris)
Marlin A, Decaudin D, Thomas CM, Gasser G.
PMID: 41259687 [PubMed - indexed for MEDLINE]
Integrated, Cross-Entity Information on Preventive Measures for Bowel, Breast, and Prostate Cancer: Evaluation Study of the Web Application "Prevent-Take-Up".
JMIR Cancer
Kestler AMR, Schwab JD, Jähnig T, Melzer MK, Zengerling F, Lukac S, Janni W, Bolenz C, Barzel A, Kestler HA, Seufferlein T.
PMID: 41259673 [PubMed - indexed for MEDLINE]
Impact of Music Relaxation Therapy and Snyder's Hope Theory-Based Nursing on Psychological and Physical Status of Postoperative Patients with Breast Cancer Undergoing Chemotherapy.
Noise Health
Fu X, Hong Y, He Y, Ren J.
PMID: 41259629 [PubMed - indexed for MEDLINE]
Study Protocol of SURVIVE HERoes (NCT06643585): Trastuzumab Deruxtecan for molecular relapse in HER2+/ Low early breast cancer with ctDNA positivity after primary therapy.
PLoS One
Pfister K, Friedl TWP, Hartkopf A, Mergel F, Huesmann S, Mehmeti F, Schäffler H, Fink A, Braun T, Heublein S, Wiesmüller L, Pantel K, Rack B, Fasching PA, Janni W.
PMID: 41259337 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 319283
Page 1 of 15965
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy